Utilidad Clínica del Inventario de Desarrollo Infantil frente a la Detección Temprana de Riesgo

Value of the Information & Strength of the Argument

The video provides substantial value by presenting original empirical evidence on the clinical utility of a national screening tool. The argumentation is solid, grounded in established psychometric frameworks and previous research. The presenter systematically addresses each study’s objectives, methods, and results, and discusses implications for policy and practice. The use of ROC curves, regressions, and convergent validity analyses strengthens the claims. The discussion of limitations and the need for further evidence adds to the credibility.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with detailed descriptions of sampling, instruments, and statistical analyses. The sources cited include the INDI itself, the national developmental surveillance guide, and standardized instruments like WIPPSI-4 and Vineland-3. The title accurately reflects the content, focusing on clinical utility and early detection. The presentation is well-structured and transparent about the research process.

The title accurately reflects the content, focusing on the clinical utility of the INDI for early risk detection.

8/10

The video is a doctoral thesis defense presenting three empirical studies with robust psychometric analyses, including ROC curves, regressions, and convergent validity. The research is grounded in established frameworks and uses validated instruments. The presentation is detailed and transparent about methods and limitations.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and welcome by the committee president.
• 02:00Maite Liz Otero begins her presentation, outlining the thesis objectives and agenda.
• 10:00Explanation of the INDI instrument, its administration, and its use in Uruguay.
• 20:00Description of the first study: convergent validity between INDI and the national developmental surveillance guide.
• 30:00Presentation of results on agreement between instruments and discussion of moderate risk detection.
• 40:00Details of the second study: predictive validity with a subsample followed up after one year.
• 50:00Results of regressions and ROC curves showing predictive power of INDI.
• 1:00:00Discussion of implications for intersectoral policy and tiered intervention models.
• 1:10:00Conclusion and final remarks by the candidate.
• 1:20:00Questions and comments from the tribunal members.

• INDI (Inventario de Desarrollo Infantil) — The instrument being validated in the thesis.
• Guía Nacional de Vigilancia del Desarrollo — Used as a comparison in the convergent validity study.
• WIPPSI-4 — Used for cognitive assessment in the follow-up study.
• Vineland-3 — Used for adaptive behavior assessment in the follow-up study.

• INDI — The instrument itself, with prior validity evidence.
• Guía Nacional de Vigilancia del Desarrollo — National clinical tool used for comparison.